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Introduction: Solid pseudopapillary neoplasm of the pancreas is a rare neoplasm that has been reported to account
for between 0.17% and 2.7% of all non-endocrine tumors of the pancreas. It is usually seen in young women. Because
solid pseudopapillary neoplasms are rarely aggressive and have low-grade malignant potential and an excellent
prognosis after complete resection, it is an ideal pancreatic tumor for treatment by minimally invasive surgery.
Therefore, making an accurate pre-operative diagnosis is very important.
Case presentation: A 24-year-old Japanese man who had been found to have mild transaminase elevations at
a medical check-up visited our hospital for further examination. Abdominal computed tomography showed a
40mm-diameter tumor in the pancreatic tail and mild fatty liver. He was admitted to our hospital for additional
examination. The abdominal contrast-enhanced computed tomography scan taken at our institution showed an
increasingly enhanced mass of 40mm diameter in the pancreatic tail. Ultrasonography showed a low-level echoic mass
of 35mm diameter in the pancreatic tail. T1-weighted magnetic resonance imaging showed low signal intensity in the
tail of the pancreas. T2-weighted magnetic resonance imaging showed high signal intensity there. Diffusion magnetic
resonance imaging showed high signal intensity. An endoscopic ultrasound yielded the same results as the abdominal
ultrasonogram. In addition, [18F]-fluorodeoxyglucose positron emission tomography/computed tomography showed
abnormal accumulation (maximum standardized uptake value, 6.53). This finding raised our suspicion of a pancreatic
malignant tumor. However, the patient could not be confidently diagnosed solely on the basis of imaging. Endoscopic
ultrasound-guided fine-needle aspiration was performed, which led us to a diagnosis of solid pseudopapillary neoplasm.
On that basis, we performed minimally invasive surgery (spleen-preserving laparoscopic distal pancreatectomy).
Conclusion: Atypical solid pseudopapillary neoplasm without cysts should be considered when diagnosing pancreatic
tumors. A definitive pre-operative diagnosis of solid pseudopapillary neoplasm made on the basis of endoscopic
ultrasound-guided fine-needle aspiration can guide the surgical approach used.
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Solid pseudopapillary neoplasm (SPN) of the pancreas
is a rare neoplasm that has been reported to account
for between 0.17% and 2.7% of all non-endocrine tumors
of the pancreas. It is usually seen in young women and is
usually asymptomatic. The lesion is generally large (2.5cm
to 10cm) and encapsulated and frequently contains vary-
ing amounts of necrosis, hemorrhage, calcification and
cystic changes [1]. Because SPN is rarely aggressive, has
low-grade malignant potential and carries an excellent
prognosis after complete resection, it should be differenti-
ated from other, more aggressive tumors, such as adeno-
carcinoma and endocrine tumors [2]. SPN is an ideal
pancreatic tumor for treatment by minimally invasive
surgery. Therefore, pre-operative accurate diagnosis is
very important. Endoscopic ultrasound (EUS)-guided
fine-needle aspiration (EUS-FNA) has recently been
established as a modality for use in the diagnosis of
pancreatic mass-related lesions.
We present a case of a patient with atypical SPN that
was diagnosed by performing EUS-FNA before surgery.
We were able to perform minimally invasive surgery (a
spleen-preserving laparoscopic distal pancreatectomy).
Our findings suggest that a definitive pre-operative diag-
nosis of SPN made on the basis of EUS-FNA findings
could guide the choice of surgical approach.Case presentation
A 24-year-old Japanese man was referred to our hospital
after a medical check-up revealed mild transaminase
elevations. He had no symptoms. He was found to
have mild fatty liver and a pancreatic mass by con-
trast-enhanced computed tomography (CT). Abdominal
contrast-enhanced CT showed an increasingly enhanced
mass of 40mm diameter in the pancreatic tail (Figure 1).
Ultrasonography (US) showed a low echoic mass of
35mm diameter in that location. T1-weighted magneticFigure 1 Abdominal computed tomography showing the solid pseud
shows a mass of 40mm diameter in the pancreatic tail. (B) This is a contras
40mm diameter in the pancreatic tail.resonance imaging (MRI) revealed low signal intensity
in the tail of the pancreas, whereas T2-weighted MRI
showed high signal intensity. Diffusion MRI showed high
signal intensity. Our EUS (GF-UM 2000; Olympus Co,
Tokyo, Japan) observations led us to the same conclusions
as the abdominal US (Figure 2). In addition, [18F]-fluoro-
deoxyglucose positron emission tomography/computed
tomography (FDG PET/CT) showed abnormal accumula-
tion (maximum standardized uptake value, 6.53) (Figure 3),
and this finding raised our suspicion of a malignant pan-
creatic tumor. However, the case could not be confidently
diagnosed solely on the imaging results. FNA was there-
fore performed via a transgastric approach with linear
EUS (GF-UCT 2000; Olympus Co), and two passes were
made with a 25-gauge needle (EchoTip Ultra(ECHO-25);
Cook Endoscopy, Winston-Salem, NC, USA). We noted
no signs or symptoms in the patient during or after
the procedure. Our histopathological findings derived
from the samples taken during the EUS-FNA procedure
included the presence of cells with round nuclei that
showed pseudopapillary growth. The tumor cells showed
immunopositivity for CD10, progesterone receptor and
vimentin (Figure 4). We diagnosed this tumor as a SPN
and performed minimally invasive surgery to resect it
(a spleen-preserving laparoscopic distal pancreatectomy)
(Figure 5). Upon examination of the resected specimen,
we determined that it was a solid tumor extending to
the tail of the pancreas. The tumor did not contain
calcified or cystic areas (Figure 6). Our histopatho-
logical findings were similar to those obtained by
EUS-FNA. The tumor cells showed immunopositivity
for β-catenin, CD10 and vimentin. Our final pathological
diagnosis was SPN of the pancreatic tail. No vascular
invasion or infiltrative growth was observed. The tumor
margin was negative. The patient’s post-operative course
was good, and he had no post-operative recurrences in
the 18-month follow-up period, during which time he
was followed in the outpatient department.opapillary neoplasm in our patient. (A) This is a plain image, and it
t-enhanced image, and it shows an increasingly enhanced mass of
Figure 2 Endoscopic ultrasound. These two images show a low echoic mass of 35mm diameter in the pancreatic tail. (The left image shows a
whole image and the right image shows an enlarged image. The dotted lines show lines of measurement for this tumor.)
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SPN is an exceedingly rare pancreatic tumor with a
reported frequency of less than 1% of all pancreatic
diseases. In most cases (about 80%), patients with SPNs
present either with pain or with a mass. The tumor is
asymptomatic in about 15% of the cases [2]. Apostolidis
et al. reported a very rare case in which hematemesis
was a presentation of SPN [3]. SPN occurs predominantly
in adolescent girls and young women. The occurrence of
SPN in men is rare, accounting only for 7% of cases [4].
Our patient, a 24-year-old man, was asymptomatic.
SPNs are generally large, with a mean diameter of 10.3cm.
Approximately 72% of them arise in the body and tail of
the pancreas. They less frequently develop in the head. In
our patient, the tumor was comparatively large (40mm in
diameter) and located in the tail of the pancreas. SPNs are
generally encapsulated and frequently contain varying
amounts of necrosis, hemorrhage, calcification and cysticFigure 3 18F-fluorodeoxyglucose positron emission tomography/
computed tomography scans of the solid pseudopapillary
neoplasm in our patient. This fused image shows abnormal
accumulation in the mass (maximum standardized uptake value, 6.53).changes [1]. However, our patient’s tumor had none of
these characteristics. In addition, a previous case of small
SPN with no cyst has been reported, suggesting that the
cyst formation, bleeding, and calcification are secondary
changes caused by tumor growth.
Because SPNs are of unclear pathogenesis and low
malignancy and surgical resection offers the patient an
excellent chance for long-term survival, these tumors
should be differentiated from other, more aggressive tu-
mors, such as adenocarcinoma and endocrine tumors [2].
The tumor characteristics on the images shown herein
have a contrast enhancement, but this enhancement is
weaker than it would be for a neuroendocrine tumor. The
T1-weighted MRI shows low signal intensity, whereas
the T2-weighted MRI shows high signal intensity. Although
few articles about PET findings of SPN have been published
to date, the frequency of these reports has increased slightly
in recent years. Dong et al. described PET scans that
showed high accumulation throughout most of the SPN.
They postulated that the FDG uptake of SPN they observed
may have been related to tumor cellularity, the prolifer-
ative index or histological malignancy [5]. Accordingly,
SPN should be included in the differential diagnosis for
pancreatic tumors with high accumulation in PET.
Most of the characteristics of our patient’s tumor were
atypical of a SPN, so we could not diagnose it solely on
the basis of imaging findings. We therefore performed
EUS-FNA to obtain a more definitive diagnosis. The his-
tologically based differential diagnosis of SPN from other
malignant pancreatic tumors is very important, because
SPN carries a much better prognosis than the other
malignant pancreatic tumors, with only 10% to 15% of
tumors recurring or metastasizing. More than 95% of
SPNs are cured by complete surgical resection alone. In
addition, it has been reported that minimally invasive
surgery for SPN can achieve a favorable curative effect
Figure 4 Histopathological images of samples taken during endoscopic ultrasound-guided fine-needle aspiration. (A) The tumor cells with
round nuclei show pseudopapillary growth (hematoxylin and eosin stain; original magnification, ×4). Immunohistochemically, the tumor cells stained
positive for CD10 (original magnification, ×10) (B), progesterone receptor (original magnification, ×10) (C) and vimentin (original magnification, ×10) (D).
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presence of a dense capsule and the excellent prognosis.
Marinis et al. reported a case of a patient with a SPN who
was treated with laparoscopic distal pancreatectomy and
concluded that SPNs are the ideal pancreatic tumors to
be treated via the laparoscopic approach [6]. However,Figure 5 Peri-operative photograph showing the pancreas.
Our patient was treated with a spleen-preserving laparoscopic distal
pancreatectomy. The pancreas (arrow) was transected using a 60mm
endoscopic gastrointestinal anastomosis stapler.it is necessary to limit the removal of tissue to preserve
as much normal pancreatic tissue as possible and to
maintain its functional structure, because the tumor is
usually found in young patients; therefore, it is important
to consider these patients’ post-operative quality of life
[7]. Accurate pre-operative diagnosis of SPN enables
treatment with minimally invasive surgery. From this
standpoint, the significance of the pre-operative patho-
logical diagnosis cannot be overstated.Figure 6 Macroscopic images of the specimen. Our examination of
the resected specimen revealed a solid tumor extending to the tail of
the pancreas. The tumor did not contain calcified or cystic areas.
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staging tool for patients with pancreatic tumors [8]. The
sensitivity and specificity of EUS-FNA for pancreatic
neoplasms have been reported to be 91% and 94%,
respectively. The overall complication rate of EUS-FNA
has been reported to be less than 1% in large centers.
From among the 1,034 patients who underwent pancreatic
EUS-FNA described in a previous report, complications
consisted of only 10 patients (0.96%) with hemorrhage,
2 (0.19%) with acute pancreatitis and 1 (0.09%) with
duodenal perforation [9].
Since Nadler et al. first described a correct diagnosis
of SPN on the basis of EUS-FNA in 2002 [10], several
SPN cases in which the diagnosis was made using this
method have been reported [11]. Song et al. summarized
the cytologic features in the 43 cases of SPN diagnosed
on the basis of EUS-FNA described in the English litera-
ture. They reported that the cytomorphologic features
observed after FNA are highly characteristic and distinct
from those of other cystic or solid tumors of the pancreas
[11]. Also, the diagnostic accuracy of EUS-FNA for SPN
was found to be 75% in another study [12]. Minimally
invasive surgery was performed in 29% of these patients.
In addition, it has been reported that the diagnosis of SPN
based on pre-operative EUS-FNA is feasible.
Conclusion
We report a case of a 24-year-old man with pancreatic
SPN without cysts. Other malignant pancreatic tumors
were considered in the differential diagnosis, but we
performed EUS-FNA to obtain a definitive diagnosis and
were able to perform minimally invasive surgery. SPN
without cysts should be considered when diagnosing
pancreatic tumors. A definitive pre-operative diagnosis
of SPN by performing EUS-FNA can guide the surgical
approach.
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